HOME >> BIOLOGY >> NEWS
Horse breath testing to benefit racing

TWO new studies into horses' health could be of major importance to the economic health of the racing industry. The studies, at Adelaide University in Australia, include breath testing of horses and a new technique to help horses recover from serious tendon injury.

BREATH TESTING

Inflammatory Airway Disease (IAD) is a lower respiratory tract disease that causes problems in the horse racing industry. Studies have found that anything up to 50% of thoroughbred and standardbred racehorses in training suffer from the disease. However, the lack of overt symptoms that accompany it, other than a general poor performance on the track, means the disease often goes unnoticed.

Current diagnostic techniques are invasive, time-consuming and limited in their ability to detect lower airway disease. But a new "breath testing" technique could change all that.

Honours student Belinda Argent, under the supervision of Dr David Tivey (Department of Animal Science, Roseworthy Campus), has conducted trials of new testing procedures for IAD in horses, the results of which are eagerly awaited by veterinarians and trainers alike.

Ms Argent's study postulates that particular components of the breath expired by horses could be used as a direct marker of inflammatory disease occurring in the lungs.

"If this is proven to be the case," Ms Argent, says "it's expected that the test will not only be more sensitive diagnostically in the early stages of the disease, but also more readily accepted and utilised by trainers which will, in turn, hopefully be more effective in reducing the degree of damage caused by IAD in the horse racing industry."

The "breath test" method is stress-free for the animal and easily administered, using a simple bagging technique to trap breath and extract samples with a syringe for laboratory testing.

Trials have been conducted at Sydney's metropolitan racetracks and
'"/>

Contact: David Ellis
david.ellis@adelaide.edu.au
618-8303-3173
Adelaide University
6-Nov-2001


Page: 1 2 3

Related biology news :

1. Trojan Horses, xenon imaging and remote controlled genes
2. Horse owners should vaccinate horses, experts say
3. Horseshoe crabs survival rate after biomedical bleeding is high
4. Science: nanoscale Trojan Horse attacks cancer cells from within
5. Horseshoe Crab Research Center provides information to improve management
6. Horseshoe crab studies providing new insight into valuable ancient creatures
7. Continuing Research On Knee Surgery For Horses At Colorado State University Holds Promise Of Helping Humans With Osteoarthritis
8. Light Shed On Mystery Horse Disease
9. Horses Prefer Bridles That Have A Bit Missing
10. Veterinarians Input On Olympics Horse Events Has Had Global Impact
11. Trojan Horse Virus Controls Hiv Infection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Horse breath testing benefit racing

(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... Dec. 3, 2014  Crossmatch™, a leading provider ... its DigitalPersona ® Pro Enterprise software and ... deployed throughout First Bank branch locations in ... Carolina and Virginia. First Bank, a progressive ... Pines, North Carolina , selected the Crossmatch ...
(Date:11/21/2014)... -- According to a new market research ... Access Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), ... Geography - Global Forecasts to 2020", published by MarketsandMarkets, ... around $25 Billion in 2014 and is expected to ... of 8.69%. Browse 116 market data Tables ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
(Date:12/19/2014)... -- Decision Resources Group finds that the Asia ... through 2023 as the aging population, increasing adoption of ... all spur procedure volumes. Growth will be particularly rapid ... and India , where rising ... a larger proportion of the population. Other ...
(Date:12/17/2014)... NY (PRWEB) December 16, 2014 The ... changes since 2013, which is why IBISWorld updated its ... industry continues to benefit from an intensified focus on ... proposal for new emission standards for power plants and ... operators. According to IBISWorld Industry Analyst Sarah Kahn, “a ...
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
Breaking Biology Technology:Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
Cached News: